ACAD Working Capital Per Revenue	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter
Y / Y Working Capital Change	72.85 %	53.45 %	28.35 %	23.75 %	-5.35 %
Y / Y Revenue Change	18.7 %	12.36 %	18.28 %	46.44 %	73.75 %
Working Capital Per Revenue	0.45	0.4	0.37	0.37	0.38
Working Capital Per Revenue Ranking	# 1574	# 0	# 2099	# 0	# 0
Seq. Working Capital Change	40.77 %	13.62 %	13.45 %	-4.75 %	24.97 %
Seq. Revenue Change	-5.89 %	3.67 %	3.49 %	17.55 %	-10.91 %

New: More ACAD's historic Working Capital Per Revenue Ratios >>

See ACAD Capital expenditures by quarter >> Back to ACAD Financial Strength Comparisons >> See ACAD Balance Sheets

Comment on ACAD's Working Capital Per Revenue in the first quarter 2025

Acadia Pharmaceuticals Inc 's Working Capital Per Revenue sequentially grew to 0.45 during the Q1 2025, below the Acadia Pharmaceuticals Inc average.

Within Healthcare sector 29 other companies have achieved lower Working Capital Per Revenue during the Q1 2025. While Working Capital Per Revenue total ranking has deteriorated in the first quarter 2025, compared to previous quarter from 0 to 1574.

Working Capital Per Revenue Ranking
Within:	No.
Industry	# 9
Sector	# 30
S&P 500	# 1574

Working Capital Per Revenue Statistics
High	Average	Low
4579.69	603.11	0.39
(March 31, 2016)		(Jun 30 2024)

Financial Statements
Acadia Pharmaceuticals Inc 's Working Capital	$ 625 Millions	Visit ACAD's Balance sheet
Acadia Pharmaceuticals Inc 's Revenues	$ 244 Millions	Visit ACAD's Income Statement
Where are ACAD's Sales coming from?		Visit ACAD's Sales by Geography

Companies with similar Average Working Capital Per Revenue for 12 months ending Mar 31 2025, within Healthcare Sector	Working Capital Per Revenue
Zevra Therapeutics Inc	1.24
Fonar Corporation	1.21
Guardant Health Inc	1.18
Jaguar Health Inc	1.14
Adaptive Biotechnologies Corporation	1.11
Tg Therapeutics Inc	1.09
Icad Inc	1.08
Staar Surgical Co	1.08
Regeneron Pharmaceuticals Inc	1.06
Fulgent Genetics Inc	1.03
Ptc Therapeutics inc	1.03
United Therapeutics Corporation	1.02
Si bone inc	1.02
Hologic Inc	0.98
Blueprint Medicines Corporation	0.97
Apyx Medical Corp	0.96
Sarepta Therapeutics Inc	0.91
Alnylam Pharmaceuticals Inc	0.91
Transmedics Group Inc	0.91
Halozyme Therapeutics Inc	0.91
Establishment Labs Holdings Inc	0.90
Orthopediatrics Corp	0.90
Macrogenics Inc	0.89
Catalyst Pharmaceuticals Inc	0.89
Iradimed Corporation	0.88
Ultragenyx Pharmaceutical Inc	0.88
Irhythm Technologies Inc	0.88
Carisma Therapeutics Inc	0.88
Castle Biosciences Inc	0.87
Alpha Teknova Inc	0.87

Date modified: 2025-05-09T07:08:30+00:00

Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright � 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com